Jones Healthcare Group Invests in New Bottling Capabilities

Article

The new Uhlmann bottle line uses Cremer technology for 100% counting accuracy and an inspection and rejection system for all critical quality parameters.

Jones Healthcare Group, a packaging and medication-dispensing solutions company, announced on June 29, 2020 that it is expanding its bottling capabilities by investing in a new, fully integrated Uhlmann bottle line.

With a filling speed of up to 150 bottles per minute, the bottle line uses Cremer technology for 100% counting accuracy and an inspection and rejection system for all critical quality parameters, a company press release said. It works with several bottle shapes, sizes, and constructions, with integrated cartoning and bundling technology.

“Our investments are driven by customer and market demand for flexible, innovative, and full-service packaging services that align with global regulatory requirements,” said Marty Quesnel, senior vice-president, Packaging Services, at Jones, in the press release. “Our new bottling capabilities complement our blistering, pouching, convenience vial filling, and secondary packaging services as well as our full serialization and aggregation solution for prescription medicines. No matter what packaging our healthcare clients need, we can deliver with speed and flexibility in a Health Canada and FDA-registered environment.” 

“We are pleased to continue our partnership with world-class pharmaceutical equipment manufacturer Uhlmann to broaden our offering with leading bottling technology,” said Ron Harris, president and CEO, Jones, in the press release. “Our ongoing investment strengthens our support for healthcare clients as an integrated supply chain partner who delivers a range of regulated packaging services and components from concept to finished product.”

The new line will be installed at the company’s facility in Brampton, Ontario, Canada, and will be operational by next year.

Source: Jones Healthcare Group

 

 

 

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content